132 related articles for article (PubMed ID: 25019345)
1. Revising the fasting glucose threshold for detection of cardiovascular risk factors: analysing two representative population-based studies of more than 50,000 Iranians in 3 years: The National Survey of Risk Factors for Non-Communicable Diseases of Iran.
Esteghamati A; Zandieh A; Hafezi-Nejad N; Sheikhbahaei S; Abbasi M; Gouya MM; Nakhjavani M
Ann Hum Biol; 2015 Mar; 42(2):150-8. PubMed ID: 25019345
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
3. Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioural risk factors.
Lecomte P; Vol S; Cacès E; Lasfargues G; Combe H; Laurent S; Tichet J
Diabetes Metab; 2002 Sep; 28(4 Pt 1):311-20. PubMed ID: 12442069
[TBL] [Abstract][Full Text] [Related]
4. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
Guerrero-Romero F; Violante R; Rodríguez-Morán M
Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
[TBL] [Abstract][Full Text] [Related]
5. [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases].
Wang W; Zhao D; Sun JY; Liu J; Qin LP; Wu ZS
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):20-4. PubMed ID: 17331382
[TBL] [Abstract][Full Text] [Related]
6. Fasting plasma glucose and Type 2 diabetes risk: a non-linear relationship.
Schulze MB; Fritsche A; Boeing H; Joost HG
Diabet Med; 2010 Apr; 27(4):473-6. PubMed ID: 20536521
[TBL] [Abstract][Full Text] [Related]
7. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
[TBL] [Abstract][Full Text] [Related]
8. Appropriate BMI cut-off values for identification of metabolic risk factors: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).
Zandieh A; Esteghamati A; Morteza A; Noshad S; Khalilzadeh O; Gouya MM; Nakhjavani M
Ann Hum Biol; 2012; 39(6):484-9. PubMed ID: 22946480
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
[TBL] [Abstract][Full Text] [Related]
10. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
[TBL] [Abstract][Full Text] [Related]
11. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
12. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
13. Impaired glucose homeostasis in non-diabetic Greek hypertensives with diabetes family history. Effect of the obesity status.
Vyssoulis GP; Liakos CI; Karpanou EA; Triantafyllou AI; Michaelides AP; Tzamou VE; Markou MI; Stefanadis CI
J Am Soc Hypertens; 2013; 7(4):294-304. PubMed ID: 23562108
[TBL] [Abstract][Full Text] [Related]
14. Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile.
Dell'Omo G; Penno G; Del Prato S; Mariani M; Pedrinelli R
J Hum Hypertens; 2009 May; 23(5):332-8. PubMed ID: 19078990
[TBL] [Abstract][Full Text] [Related]
15. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011.
Esteghamati A; Etemad K; Koohpayehzadeh J; Abbasi M; Meysamie A; Noshad S; Asgari F; Mousavizadeh M; Rafei A; Khajeh E; Neishaboury M; Sheikhbahaei S; Nakhjavani M
Diabetes Res Clin Pract; 2014 Feb; 103(2):319-27. PubMed ID: 24447808
[TBL] [Abstract][Full Text] [Related]
16. Classical cardiovascular risk factors according to fasting plasma glucose levels.
Martinez-Hervas S; Romero P; Hevilla EB; Real JT; Priego A; Martin-Moreno JM; Carmena R; Ascaso JF
Eur J Intern Med; 2008 May; 19(3):209-13. PubMed ID: 18395166
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults.
Samaras K; Crawford J; Lutgers HL; Campbell LV; Baune BT; Lux O; Brodaty H; Trollor JN; Sachdev P
J Am Geriatr Soc; 2015 Jul; 63(7):1435-42. PubMed ID: 26147402
[TBL] [Abstract][Full Text] [Related]
18. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of abnormal fasting plasma glucose among the university hospital employees in Thailand.
Jiamjarasrangsi W; Lohsoonthorn V; Lertmaharit S; Sangwatanaroj S
Diabetes Res Clin Pract; 2008 Feb; 79(2):343-9. PubMed ID: 17953998
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease risk factors in a Nigerian population with impaired fasting blood glucose level and diabetes mellitus.
Oguoma VM; Nwose EU; Ulasi II; Akintunde AA; Chukwukelu EE; Bwititi PT; Richards RS; Skinner TC
BMC Public Health; 2017 Jan; 17(1):36. PubMed ID: 28061844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
